| FSTL3 |
FSTL3, FLRG, UNQ674/PRO1308: Follistatin-related protein 3 precursor |
INHBB |
INHBB: Inhibin beta B chain precursor |
2.63 |
Evidence |
|
| FZD7 |
FZD7: Frizzled-7 precursor |
GRIA1 |
GRIA1, GLUH1, GLUR1: Glutamate receptor 1 precursor |
2.63 |
Evidence |
|
| FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
2.63 |
Evidence |
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
2.63 |
Evidence |
|
| PEX7 |
PEX7, PTS2R: Peroxisomal targeting signal 2 receptor |
TAF12 |
TAF12, TAF15, TAF2J, TAFII20: Transcription initiation factor TFIID subunit 12 |
2.63 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
2.63 |
Evidence |
|
| ANK1 |
ANK1, ANK: Ankyrin-1 |
CARD8 |
CARD8, KIAA0955, NDPP1: Caspase recruitment domain-containing protein 8 |
2.622 |
Evidence |
|
| NFKB1 |
IPI00292537 |
CARD11 |
CARD11, CARMA1: Caspase recruitment domain-containing protein 11 |
2.622 |
Evidence |
|
| SCN11A |
SCN11A, PN5, SCN12A, SNS2: Sodium channel protein type 11 subunit alpha |
PKD2 |
IPI00718868 |
2.622 |
Evidence |
|
| TRPV4 |
IPI00657947 |
KCNA10 |
KCNA10, Kcn1, RP11-470L19.4-001, hCG_1647453: Potassium voltage-gated channel su |
2.622 |
Evidence |
|
| BLNK |
IPI00718885 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
2.622 |
Evidence |
|
| HCN4 |
HCN4: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated chann |
PKD2 |
IPI00718868 |
2.622 |
Evidence |
|
| TRPC6 |
TRPC6, TRP6: Short transient receptor potential channel 6 |
MFN1 |
MFN1: Mitofusin-1 |
2.622 |
Evidence |
|
| SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
NTRK3 |
IPI00289961 |
2.622 |
Evidence |
|
| BHLHB3 |
BHLHB3, DEC2, SHARP1: Class B basic helix-loop-helix protein 3 |
MYCL1 |
MYCL1, LMYC, MYCL: L-myc-1 proto-oncogene protein |
2.622 |
Evidence |
|
| BCL2L14 |
BCL2L14, BCLG: Apoptosis facilitator Bcl-2-like 14 protein |
BCL2L12 |
BCL2L12, BPR: Bcl-2-related proline-rich protein |
2.622 |
Evidence |
|
| BBC3 |
BBC3, PUMA: Bcl-2-binding component 3 |
BCL2L14 |
BCL2L14, BCLG: Apoptosis facilitator Bcl-2-like 14 protein |
2.622 |
Evidence |
|
| ASCL2 |
ASCL2: Achaete-scute homolog 2 |
TCFL5 |
TCFL5, CHA, E2BP1: Transcription factor-like 5 protein |
2.622 |
Evidence |
|
| TCF12 |
TCF12, HEB, HTF4: Transcription factor 12 |
PHTF1 |
PHTF1, PHTF: Putative homeodomain transcription factor 1 |
2.622 |
Evidence |
|
| BMF |
BMF: Bcl-2-modifying factor |
BOK |
BOK: Bcl-2-related ovarian killer protein |
2.622 |
Evidence |
|
| BMF |
BMF: Bcl-2-modifying factor |
BCL2L12 |
BCL2L12, BPR: Bcl-2-related proline-rich protein |
2.622 |
Evidence |
|
| BMF |
BMF: Bcl-2-modifying factor |
BBC3 |
BBC3, PUMA: Bcl-2-binding component 3 |
2.622 |
Evidence |
|
| NULL |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-38 alpha chain precursor |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
2.622 |
Evidence |
|
| BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
BCL2L14 |
BCL2L14, BCLG: Apoptosis facilitator Bcl-2-like 14 protein |
2.622 |
Evidence |
|
| DEDD2 |
DEDD2, FLAME3, PSEC0004: DNA-binding death effector domain-containing protein 2 |
ANK1 |
IPI00297532 |
2.622 |
Evidence |
|